Behavioural changes have a major impact on the quality of life of patients with neurodegenerative diseases. Cummings and Zhong discuss how new tools for studying behaviour and improved clinical trial methodologies are facilitating drug development for this large unmet medical need.
- Jeffrey L. Cummings
- Kate Zhong